Treatment of graves' ophthalmopathy with cyclosporin a
- 25 Downloads
To evaluate the effect of Cyclosporin A in the management of Graves' ophthalmopathy, we treated 13 patients with severe euthyroid endocrine eye disease with the immunosuppressive drug. Follow up consisted of clinical investigation, laboratory evaluation with detailed thyroid function tests and complete ophthalmological assessments including A and B scan ultrasound and computerized tomography (CT) of the orbits. Cyclosporin A given over 4–7 months resulted in improvement of clinical signs and symptoms of the disease due to a positive effect of the drug on soft tissue changes. The more objective methods did not demonstrate any unequivocal change in proptosis, visual acuity, intraocular pressure and thickness of extraocular muscles. Cyclosporin A was not able to stop acute progression of ophthalmopathy in one patient and did not obviate surgical decompression of the orbits in two more patients. There was no measurable effect of treatment on the underlying immunological process with regard to thyroid disease.
Key wordsGraves' ophthalmopathy Cyclosporin A ultrasonogram computerized tomography proptosis extraocular muscle thickness
thyroxine binding globulin
TSH displacing activity
thyroid stimulating hormone
Unable to display preview. Download preview PDF.
- 1.Beveridge T (1982) Cyclosporin A, 1st edn, Elsevier Biomedical Press, Amsterdam, pp 561–564Google Scholar
- 6.Erhardt F, Marschner I, Pickardt CR, Scriba PC (1973) Verbesserung und Qualitätskontrolle der radioimmunologischen Thyrotropin-Bestimmung. J Clin Chem Clin Biochem 11:381–387Google Scholar
- 10.Markl A, Boergen KP, Hasenfratz G, Mayr B, Fink U, Lissner J (19884) Cumputerized tomography in the evaluation of endocrine ophthalmopathy. Acta Endocrinol 105 Suppl 264:84Google Scholar
- 11.Ossoinig KC (1984) Ultrasonic diagnosis of Graves' ophthalmopathy. In: Gorman CA et al. (eds) The eye and orbit in thyroid disease. Raven Press, New York, pp 185–211Google Scholar
- 16.Witte A, Habermann J, Pickardt CR (1982) Is TSH-displacing activity a helpful parameter in diagnosis and follow-up of Graves' disease. Acta Endocrinol Suppl 246:73Google Scholar